Supernus Pharmaceuticals
SUPN
#4268
Rank
C$2.59 B
Marketcap
$46.55
Share price
0.77%
Change (1 day)
3.39%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.07

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.12. In 2022 the company made an earnings per share (EPS) of $1.61 an increase over its 2021 EPS that were of $1.45.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.07-33.31%
2022$1.6110.78%
2021$1.45-57.68%
2020$3.4312.09%
2019$3.060.47%
2018$3.0489.38%
2017$1.61-38.59%
2016$2.62534.48%
2015$0.41-211.54%
2014-$0.37-91.1%
2013-$4.1539.46%
2012-$2.98-69.27%
2011-$9.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$27.47 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.72 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.64 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.23 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.03 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA